These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 23714666

  • 1. [Significance of myc gene rearrangement and its correlation with prognosis in diffuse large B cell lymphoma].
    Zhang HW, Chen ZW, He JX, Zheng YP, Han WE, Zhao ZQ, Bai W, Wang JF.
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):119-23. PubMed ID: 23714666
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Green TM, Young KH, Visco C, Xu-Monette ZY, Orazi A, Go RS, Nielsen O, Gadeberg OV, Mourits-Andersen T, Frederiksen M, Pedersen LM, Møller MB.
    J Clin Oncol; 2012 Oct 01; 30(28):3460-7. PubMed ID: 22665537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
    Molina TJ, Canioni D, Copie-Bergman C, Recher C, Brière J, Haioun C, Berger F, Fermé C, Copin MC, Casasnovas O, Thieblemont C, Petrella T, Leroy K, Salles G, Fabiani B, Morschauser F, Mounier N, Coiffier B, Jardin F, Gaulard P, Jais JP, Tilly H.
    J Clin Oncol; 2014 Dec 10; 32(35):3996-4003. PubMed ID: 25385729
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N, Uner A, Benekli M, Barista I.
    Cancer; 2012 Sep 01; 118(17):4173-83. PubMed ID: 22213394
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of BCL-6, MYC and p53 gene abnormalities with immunological subtypes and prognosis of diffuse large B-cell lymphoma].
    Sun GX, Cao XS, Li Q, Wang ZL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct 01; 29(5):576-81. PubMed ID: 23042398
    [Abstract] [Full Text] [Related]

  • 8. MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
    Perry AM, Alvarado-Bernal Y, Laurini JA, Smith LM, Slack GW, Tan KL, Sehn LH, Fu K, Aoun P, Greiner TC, Chan WC, Bierman PJ, Bociek RG, Armitage JO, Vose JM, Gascoyne RD, Weisenburger DD.
    Br J Haematol; 2014 May 01; 165(3):382-91. PubMed ID: 24506200
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.
    Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A.
    J Clin Oncol; 2010 Jul 10; 28(20):3360-5. PubMed ID: 20498406
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma.
    Zhang HW, Chen ZW, Li SH, Bai W, Cheng NL, Wang JF.
    Hematol Oncol; 2011 Dec 10; 29(4):185-9. PubMed ID: 21692100
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
    Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW.
    Histopathology; 2008 Aug 10; 53(2):205-17. PubMed ID: 18752503
    [Abstract] [Full Text] [Related]

  • 14. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
    Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS.
    Int J Med Sci; 2019 Aug 10; 16(4):556-566. PubMed ID: 31171907
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
    Li M, Liu CL, Wang XY, Xue XM, Gao ZF.
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec 10; 41(12):813-7. PubMed ID: 23324229
    [Abstract] [Full Text] [Related]

  • 16. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
    Thieblemont C, Briere J, Mounier N, Voelker HU, Cuccuini W, Hirchaud E, Rosenwald A, Jack A, Sundstrom C, Cogliatti S, Trougouboff P, Boudova L, Ysebaert L, Soulier J, Chevalier C, Bron D, Schmitz N, Gaulard P, Houlgatte R, Gisselbrecht C.
    J Clin Oncol; 2011 Nov 01; 29(31):4079-87. PubMed ID: 21947824
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
    Min M, Lin L, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.
    Zhonghua Zhong Liu Za Zhi; 2012 Feb 01; 34(2):110-6. PubMed ID: 22780928
    [Abstract] [Full Text] [Related]

  • 18. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
    Zhang HW, Chen ZW, Wang LY, He JX, Zheng YP, Han WE, Yang B, Wang YL, Zhao ZQ, Bai M, Su LP.
    Zhonghua Zhong Liu Za Zhi; 2016 Mar 23; 38(3):206-10. PubMed ID: 26988827
    [Abstract] [Full Text] [Related]

  • 19. Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
    Copie-Bergman C, Gaulard P, Leroy K, Briere J, Baia M, Jais JP, Salles GA, Berger F, Haioun C, Tilly H, Emile JF, Banham AH, Mounier N, Gisselbrecht C, Feugier P, Coiffier B, Molina TJ.
    J Clin Oncol; 2009 Nov 20; 27(33):5573-9. PubMed ID: 19786664
    [Abstract] [Full Text] [Related]

  • 20. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
    Yao XX, Wang JF, Wang YH, Gao N.
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun 20; 41(6):366-70. PubMed ID: 22932402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.